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Abstract
Objectives: Cognitive stimulation therapy (CST) is a brief, non-pharmacological intervention for
people with dementia, with an established evidence base for improving cognition and quality of life. It
is widely implemented in National Health Service (NHS) settings, but little is known about its
naturalistic use. The aim of this survey was to identify and explore inclusion criteria, dose and quality
of CST across services in Great Britain (England, Scotland and Wales).
Methods:All NHSmemory clinics and services for people with dementia were contacted and asked
to complete a mixed methods online survey on CST delivery in their service. Questions were
centred on who provided CST, who received CST, the dose of CST and any outcomes that were
routinely measured.
Results: A total of 57/186 services responded, giving a response rate of 30.7%. While the
majority reported offering CST (87.7%), there was variability in how this was delivered. Differing
inclusion criteria included the use of varying cognitive and behavioural outcome measures, and
CST was reported as being offered once and twice weekly. Services also differed in how they
evaluated the quality of CST and how this evidence was incorporated for future sessions.
Conclusion:While there was a low response rate, this survey indicates that there is significant
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variability in how CST is used in clinical practice, with many trusts not adhering to the evidence
base. To ensure that people with dementia are consistently offered evidence-based, high-quality
CST across NHS settings, further standardisation of inclusion criteria, dose and outcomes is
needed.
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Introduction
Cognitive stimulation therapy (CST) is a brief, manualised psychosocial therapy for people with
Alzheimer’s disease and other dementias (Aguirre et al., 2011; Spector et al., 2006; Yates et al.,
2014). While other generalised programmes exist, manualised CST as developed in the United
Kingdom has a consistent evidence base for improving cognition and quality of life (Lobbia et al.,
2018; Spector et al., 2010, 2003). Evidence also suggests that CST may enhance confidence and
motivation (Spector et al., 2011), and it has been consistently recommended for use by the National
Institute for Health and Care Excellence since 2006 (NICE, 2006, 2018).
CST was designed to be a low-cost intervention that could be delivered by professionals from
a range of backgrounds, and it has been suggested as more cost-effective than treatment as usual
(Knapp et al., 2006). No educational qualification criteria are listed for potential facilitators, but it is
suggested that they have some experience of working with people living with dementia (Spector
et al., 2006) and attend a 1-day training session.
As delivered according to the evidence base, group CST consists of 14, 45-minute sessions
delivered twice weekly over seven weeks, giving a total intervention time of 10.5 hours. Sessions
are based on eight fundamental principles which include mental stimulation, promoting new ideas,
thoughts and associations, a focus on opinions rather than facts, maximising the potential of
people with dementia, respect and person-centredness. Other formats have recently been evaluated
and include maintenance CST (MCST) delivered straight after the initial 14 sessions. Evidence
suggests that MCST also improves quality of life and can help to improve the cognition of those
taking anticholinesterase inhibitors (Orrell et al., 2014). Most recently, individualised CST (iCST)
delivered by family carers to their relative or friend with dementia (Orrell et al., 2017) was
evaluated. Whilst this programme improved the relationship between people with dementia and
their family carers, as well as carers’ quality of life, there were no significant changes in cognition
and quality of life.
Both the robust evidence base and ease of use have contributed to extensive use of CST, with
a recent audit suggesting 90% of memory clinics offer access to group CST (Royal College of
Psychiatrists, 2016). This suggests widespread implementation in the UK National Health
Service (NHS). However, how CST is delivered in a naturalistic setting can vary widely, with
significant differences reported in training sessions (Streater et al., 2017). This suggests that CST
may not always be delivered in ways that are consistent with the underlying evidence base. This
has the potential to significantly impact the quality of CST for people with dementia, but the
exact extent of this variability is unknown. Thus, the aims of this survey were to (1) identify
prevalence of CST provision in services for older adults with dementia in Great Britain, (2)
explore differences in CST delivery including the inclusion criteria and dose, (3) explore how the
quality of CST is maintained and 4) identify common outcomes and make recommendations for
standardisation.
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Methods
Design
A mixed method, cross-sectional survey was conducted to obtain in-depth information about
provision of CST within NHS dementia services across England, Scotland and Wales.
Recruitment
Memory clinics in Great Britain (England, Scotland and Wales) were identified via the Memory
Service National Accreditation Programme (MSNAP), and internet searches were conducted to
identify further NHS services that specified that they offered support to people with mild to
moderate dementia or offered ‘cognitive stimulation’. Internet searches included key words such as
‘NHS’, ‘Memory’, ‘Cognitive stimulation’, ‘Dementia’, ‘group interventions’ and ‘individual
interventions’. Information was retrieved from NHS Trust websites and NHS Choices website
resulting in a list of 186 services across 64 NHS trusts. No contact information was traceable for two
services. Identified services included memory clinics, day centres and hospitals.
Procedure
Services were initially approached using telephone calls or emails. If the first point of contact was
a telephone call, then the nature of the call was explained, and a request was made for the call to be
directed to the professional who would be most likely to act as a respondent for the survey. This
respondent was a member of staff who currently administered or supervised CST provision for their
organisation and could include psychologists, occupational therapists, support workers, nurses or
other allied professionals. Once identified, the respondent was invited to take part in the survey via
an email, which contained the study link. Email invites were sent via the MSNAP discussion
platform and Contact Help Advice Information Network; an online NHS network. These invites
included the online link and the contact details of the researcher, whom participants were advised to
contact should they have any questions preceding, during or following completion of the survey.
Dementia services that did not offer CST were encouraged to complete the initial questions in the
survey. Ethical permissions were obtained from University College London ethics committee, and
all participants were presented with an information sheet and required to provide informed consent.
The survey was not available to view until this was given.
Survey
The questionnaire was developed iteratively by the authors and in consultation with the MSNAP
team. Initially, draft questions were generated and reviewed for relevance and clarity by the study team.
Small changes were subsequently made to item wording. The final survey consisted of 45 possible
closed- and open-ended questions on the provision and delivery of CST in each setting, yielding
quantitative and qualitative data. The number of questions presented differed dependent on selected
answers. For instance, if a service did not provide CST, the respondent was only presented with
a maximum of seven questions. These seven questions pertained to whether CST had been offered in
the past and why it was no longer provided. The survey was administered and stored online using
Qualtrics software. Data collected included inclusion and exclusion criteria, dose, job roles of CST
facilitators and supervisors, how quality wasmeasured and routine outcomemeasurement. Participants
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were asked to provide their job title and the NHS trust they worked for, but no identifiable information
was collected.
Analysis
All survey responses were downloaded into Excel for data cleaning. Incomplete survey responses
were deleted on a case-wise basis, and completed initial questions were saved separately. Quan-
titative data were analysed using frequency and descriptive statistics in the Statistical Package for
Social Sciences. Thematic analysis (Braun & Clarke, 2006) was used for qualitative data to identify
themes and sub-themes for open-ended questions. All responses were coded; patterns within the
response were identified from every response. The final themes and sub-themes were developed
from the initial coding.
Results
Response rate
Initially 41 completed surveys were returned from 186 services. A further 100 telephone calls were
made, and 88 emails were sent to non-responders, resulting in the submission of an additional 16
surveys, giving a total of 57 and response rate of 30.7%. However, not all participants completed all
sections of the survey and some gave uninterpretable responses. As such, the total sample size (n)
differs by survey item.
Services offering CST
A majority reported that their service offered manusalised CST (87.7%, 50/57), as described in the
introduction, whilst seven reported no CST provision. Of the services that did not directly provide
CST, two reported CST via external provision (28.6%, 2/7) and five reported no external provision
(71.4%, 5/7). Of these seven services that had never directly offered CST, six services had never
provided CST (85.7%, 6/7), and one service reported that they had discontinued CST having
previously offered it for 5 years (14.3%, 1/7). CST was discontinued in this service after a man-
agerial review resulted in a move to support third sector organisations to provide CST instead.
Inclusion criteria for CST
Inclusion criteria at a participant level varied across services. In data obtained from 50 respondents,
four themes were identified as part of inclusion criteria listed by services: (1) diagnosis, (2) ability,
(3) internal factors and (4) external factors (Table 1).
Themes 1 and 2: Diagnosis and ability. There was a predominant focus on clinical diagnosis, cognitive
impairment and the use of cut-offs on formal measures of cognition. For example one exclusion
criterion was an Addenbrooke’s Cognitive Examination Revised (ACE-R) score of <60. There were
also instances where people with mild cognitive impairment were included. However, service user
ability occurred the most out of four themes. This included hearing and visual impairments as well as
mobility, communication and cognitive ability. A number of services also excluded service users if
they were deemed to lack capacity to provide informed consent.
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Table 1. Inclusion and exclusion criteria for provision (n = 50/57).
Theme Definition Occurrence Sub-theme
Example
Inclusion Criterion Exclusion criterion
Diagnosis Professional
assessment of
impairment and/
or clinical
diagnosis
47 Diagnosis Formal diagnosis of
dementia
Non-dementia
diagnosis. No
cognitive
impairment
Degree of
impairment Mild to moderate
dementia or mild
cognitive
impairment
Moderate to severe
dementia
presentation
Use of cognition
measures
Mini-Mental State
Examination
score of 14–22
Addenbrooke’s
Cognitive Exam
revised score <60
Ability Physical or cognitive
capability to
access
information
provided by the
training or the
manual
49 Visual/auditory No significant
hearing or visual
impairment that
would impact on
group
engagement
Auditory or visual
impairments that
are not resolved
with aids (e.g.
hearing aids or
glasses)
Physical
Able to participate/
able to sit for the
duration of the
group
Co-morbid physical
health problems
that would affect
attending weekly
sessions
Cognitive
Patient has capacity
to make
decisions about
the activities that
he/she would like
to engage in
Lacks capacity to
consent to the
group
Communication
Ability to
communicate in
a group setting
Unable to
communicate well
enough to
participate in the
group
Internal
factors
Individual
characteristics
determined by the
service providing
the intervention
28 Behaviour Able to stay in the
group setting for
1 hour
High levels of
agitation or
distress
Motivation
Motivation to
engage in the
group
Does not consent to
the group
Independence
Independent
personal care
Housebound/unable
to attend clinic
(continued)
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Theme 3: Internal factors. Internal factors were specifically related to the person with dementia’s
characteristics and their ability to participate in CST activities. Behaviour, and most commonly
agitated behaviour, was included in a number of services’ exclusion criteria. Commitment and
motivation were also prominent with service users who were unable or unwilling to commit to a full
CST intervention were excluded. Finally, the sub-theme of ‘independence’ was identified, with
residing in a nursing or residential care facility used as an exclusion criterion. Service users were also
required to be capable of attending to their own personal care during sessions in some services.
Theme 4: External factors. External factors were identified as criteria that were not under the control
of service users. Most commonly, this was related to transport. One service appeared to provide this
transport as the criterion was listed as ‘be able to use transport facilities provided’. However, no other
instances of transport being provided were identified, and participants were excluded if they were
unable to travel to and from the service for CST sessions. Another sub-theme, entitled prior support,
was used for participants for whom prior attendance at previous groups was a requirement for
acceptance to CST. Such groups were commonly newly diagnosed support groups. The final sub-
theme was ‘staff or service factors’, where services listed additional criteria such as the provision of
an allocated care coordinator for service users.
CST dose
CST provision varied greatly across services with regard to duration, group size (Table 2), frequency,
total sessions provided and session tailoring. For frequency, 51% (25/49) services offered CST twice
weekly and 42.9% (21/49) offered weekly sessions. Of the 6.1% (3/49)who selected ‘other’, one
provided ‘three cohorts’ a week with no further details on frequency, one stated they ran sessions
once a week but only for 4 months of the year. The final response in this category noted the frequency
Table 1. (continued)
Theme Definition Occurrence Sub-theme
Example
Inclusion Criterion Exclusion criterion
External
factors
Circumstances
extrinsic to
dementia
diagnosis
10 Transport Able to travel to
clinic (education
course for
informal carers
runs
concurrently to
facilitate this)
Inability to travel
Prior support
Has completed
newly diagnosed
group
Attending day
servicesStaff/service
Participants require
an allocated care
coordinator for
length of sessions
No cluster, or
clusters other than
18/19
Clusters 18 and 19 refer to people classified as having additional needs requiring shortened and simplified activities
6 Dementia 0(0)
as ‘between 0 and 10’. While it is likely this referred to cohorts rather than weekly frequency of the
same CST group, a definitive statement cannot be made.
Of the 45 participants who provided interpretable data, 44.4% (20/45) offered the full 14 sessions.
Many services 77.8% (35/45) did not offer extended or MCST sessions. However, 31% (14/45) of
responders reported that they offered further sessions when needed. Of the services that provided CST
sessions (50/57), 74.1% (22/57) offered different groups for differing levels of ability/severity of
impairment. However, of these services, 59.3% (16/57) reported that they did not specifically adapt or
change the provision of CST for different ability across service users. Further to this, 66.7% (38/57) of
services did not offer further group options such as gender specific groups for variable levels of
English. A majority of carers were also offered concurrent support 68.4% (39/57), whilst 17.5% (10/
57) services reported they offered no support or services to carers or family members of CST
participants.
CST facilitators
Each service had between two and seven members of staff who were currently responsible for fa-
cilitating CST sessions (n = 30, M = 3.4, SD = 1.48). However, 21 results for this particular question
were uninterpretable and two respondents did not answer. Examples of uninterpretable answers
included a string of digits or text, potentially entered to allow responders to move on to the next
questionwithout answering. As respondents were able to select all applicable professionals involved in
facilitating CST, there was a total of 129 professions listed, with CST facilitators most commonly
support workers 25.6% (33/129) or occupational therapists (24%, 31/129; Table 3). Of the 49 services
that provided data for this item, CST facilitators were offered clinical supervision in 43 services, whilst
six were offered no clinical supervision. Supervision was most commonly provided on amonthly basis
48.8% (21/43) but was also reported to be offered weekly 16.3% (7/43), ad hoc 11.6% (5/43), after
each session 6.98% (3/43), every 6 weeks 6.98% (3/43) or quarterly 6.98% (3/43). One responder
noted that they were unsure how often supervision was offered. As professions of supervisors could be
listed, a total of 51 responses were recorded. Supervisors were most likely to be psychologists 29.4%
(15/51) or occupational therapists 19.6% (10/51). Less commonly, CST facilitators were supervised by
assistant psychologists 1.96% (1/51), clinical leads 1.96% (1/51), line managers 1.96% (1/51), another
team member 1.96% (1/51) or trainee psychologists 1.96% (1/51; Table 3).
CST quality
Three themes were identified for assessing and monitoring the quality of CST: external, internal and
service user. External consisted of three sub-themes: CST manual, external training and literature.
CST facilitators noted that, to ensure the quality of CST remained, they regularly referred to and
continued to use the CST manual. In many cases, this was the only way the service ensured the
Table 2. Variation in cognitive stimulation therapy provision across Great Britain.
Detail N Mean SD Range
Session Length (minutes) 49 90 33.1 45–210
Average group size 44 7.6 2.4 2–12
Minimum group size 37 4.4 2.5 2–12
Maximum group size 36 9.6 1.4 6–12
Groups facilitated (per year 31 10 16.1 1–90
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standard of provision remained high: ‘We adhere to the manual’. External training referred to the
undertaking of external training on CST. Staff facilitating CST sessions noted that they had attended
the initial CST training for facilitators. However, responses also indicated that one member of the
team had completed the training and relayed the information back: ‘Someone from the day hospital
went on the training and has worked with the psychologist to deliver groups’. Finally, for the third
theme, services also noted that they ‘keep updated on Evidence Based Practice’.
The second theme referred to actions undertaken by services that aimed to ensure quality of
provision was maintained. The first sub-theme was supervision, which was prominent across the
trusts. A number of services included observational supervision: ‘each staff member is observed in
their ability to facilitate the group prior to being the lead facilitator’. Further to this, services also
reported: ‘evaluating each session as a team’. The sub-theme audit described conducting regular
audits in order to provide a continuous high standard of care provision. The final and least common
theme was service users, which included the use of feedback forms and outcome measures.
Outcome monitoring
Of 49 respondents who provided data, 46 reported monitoring outcomes associated with CST. Out-
comes monitored consisted of quality of life 67.4% (31/46), quality of provision 58.7% (27/46) and
cognition 56.5% (26/46). However, each of these outcomes was measured in varying formats across
services. Quality of life was stated to have been measured using formal outcome measures, feedback
forms and qualitative interviews. Similarly, cognition was evaluated using outcome measures, by
observation, using feedback forms fromparticipants and as part of formal qualitative interviews. Quality
of provision was evaluated using audits and observation of sessions. For cognition, outcome measures
used were the Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA)
and the Addenbrookes Cognitive Examination (ACE-III). However, no respondents gave details of the
specific quality of life measures used.
Table 3. Professions of CST facilitators and supervisors.
n %
Professions of CST facilitators Support Worker 33 25.6
Occupational therapist 31 24
Nurse 20 15.5
Clinical psychologist 14 10.9
Healthcare assistant 10 7.8
Other 21 16.3
Missing 2 4.4
Professions of CST supervisors Psychologist 15 29.4
Occupational therapist 10 19.6
Team manager 7 13.7
Team lead 5 9.8
Staff nurse 3 5.9
Nurse practitioner 2 3.9
Team member 1 3.6
Trainee psychologist 1 3.6
Other 7 13.7
CST: cognitive stimulation therapy.
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Discussion
CST is an evidence-based intervention for dementia that is widely implemented in NHS settings.
This mixed methods national survey evidences that, whilst provision of CST is high, there is
significant variability in its implementation and use across NHS settings Great Britain. Whilst the
response rate of 57 complete responses from 186 services was low, these variations are significant
and are likely to impact on both who is offered CSTand how effective it is for them. Thus, there may
be a need to adopt standardised criteria for the provision and delivery of CST in NHS settings.
Variation in inclusion and exclusion criteria indicated that access to CST differed across services.
Further, it was unclear how these criteria were applied and could be based on objective outcome
measures or subjective opinions of staff. Some exclusion criteria, such as lacking capacity to
consent, were common across services. For those that did not specify this criterion, it was unclear if
there were provisions in place to ensure that people with dementia who lacked capacity were still
offered appropriate interventions such as CST. Further to this, agitation was commonly listed as an
exclusion criterion, but it is unclear how this was applied in practice. For example it was not clear
whether this information was gathered from care notes, from carers or from formal assessments by
professionals. Notably, participants could also be excluded from CST for deficits in communication,
despite evidence suggesting CST may improve communication skills for people with dementia
(Spector et al., 2003, 2010, 2011).
CST dose was also rarely in accordance with the evidence base, with 20/50 services offering
sessions once a week over 14 weeks instead of twice weekly for seven weeks. Session length varied
from under 45 minutes per session to two-hour sessions. It was unclear why the frequency and
session length were changed for these services but may have been due to practical implementation
issues including staff availability. This has important implications as the evidence base suggests
weekly CSTmight not be as effective (Cove et al., 2014). The majority of services offered the full 14
sessions of CST, but some offered considerably less. For example 2.2% (1/45) offered only one
session and 8.9% (4/45) offered two sessions. Further, despite evidence suggesting MCST can also
be effective (D’Amico et al., 2015; Orrell et al., 2014; Streater et al., 2012), a large proportion of
respondents offered no further sessions or continuation of CST after the initial group had ended.
CSTwas designed to be delivered with minimal training requirements and specialist knowledge.
Evidence from this survey suggests that in keeping with the original evidence base, CST was
successfully delivered by a range of professionals including support workers and clinical psy-
chologists. However, it was more common for only one of the facilitators to attend formal training on
CST, with feedback from the trained facilitator and the manual used to equip co-facilitators. This
may dilute the effects of training if information is not passed on effectively but does have the
advantage of enabling a cascade training model thereby reducing training costs. Clinical super-
vision, an important means of ensuring the therapeutic value of sessions, was used variably from
a low of quarterly to a high of weekly.
The benefits of CST in clinical practice were hard to quantify as methods used varied con-
siderably. Evaluation of benefits to people with dementia could consist of observation, feedback
from recipients or the use of standardised outcome measures, and it was unclear how this data were
used in practice. Differing outcomes may be based on usual practice at each NHS site but limits the
degree to which cross-service comparisons can be made. The use of different outcome measures
were identified for cognition, whilst the specific measures used for quality of life were not detailed.
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Methodological problems and limitations
The response rate for this survey was low, and consequently, responses here may not have been
representative of all CST provision across England, Scotland and Wales. Whilst recontacting
services did improve the response rate, many memory clinics and other services did not provide data.
It is unclear why the response rate was low and could be due to staff availability and resources or
perceived non-importance of the survey. To increase the response rate in future, it may be advisable
to incentivise participation or liaise with management to ensure staff are granted reasonable time and
resources to participate.
The survey was mixed methods with open-ended questions. This was designed to capture the
variability between services but led to some uninterpretable responses. For example some responses
contained a random string of digits, potentially allowing the responder to move on to the next
question without giving a response.
Implications for practice and future research
Differing methods for collecting and assessing outcomes associated with CST indicates a potential
need to determine standardised inclusion criteria, dose and a core outcome set (COS). The COS is
an agreed minimum set of outcomes that should be measured in all clinical trials (Clarke, 2007).
Whilst clinical trials undoubtedly differ from clinical practice, the COS is a methodologically
robust way of ensuring that the effectiveness of CST is assessed reliably across services. The
evidence base for CSTwas established using the ADAS-Cog (Rosen et al., 1984) and the Quality
of Life in Alzheimer’s Disease Scale (Logsdon et al., 1999; Spector et al., 2003). Whilst the
Alzheimer's Disease Assessment Schedule-Cognitive Subscale (ADAS-Cog) may not be suitable
for clinical practice, its comparison with other more commonly used measures of cognition in
further formal research studies of CST could support the identification of a suitable cognition
outcome for both. Standardisation of outcomes may lead to a minimum dataset of the effectiveness
of CST as used in practice, with other measures added as required by services. Such data can
subsequently be used to inform practice, where staff use results to inform future facilitation. This
will help to ensure that CST delivery remains of a high standard and ensure that people with
dementia always receive high-quality, evidence-based CST. Further, an anonymised dataset could
be created from these data to facilitate comparisons in the effectiveness of CST across services.
Data collected here only pertain to NHS settings. Whilst implementation may be high here, the
degree to which CST is used and the differences in provision in other settings are unclear. Therefore,
this survey could be expanded upon and repeated in the private sector to include care homes and
private clinics. An evaluation of any differences in use and provision in either setting may further
inform implementation in the other.
Conclusion
Whilst the implementation of CST is high in NHS settings, in practice, it is delivered variably.
Across England, Scotland and Wales, there were documented differences in whom CST is offered,
the dose of what they were offered and the outcomes routinely measured. This variability precludes
an analysis of how effective CST is, as delivered as part of care. It is recommended that standardised
criteria and outcomes are adopted to ensure that CST is both delivered to a high standard and that
people with dementia consistently receive high-quality, evidence-based interventions.
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